ATE297391T1 - Indolderivate zum gebrauch in der behandlung von zns-störungen - Google Patents

Indolderivate zum gebrauch in der behandlung von zns-störungen

Info

Publication number
ATE297391T1
ATE297391T1 AT01940240T AT01940240T ATE297391T1 AT E297391 T1 ATE297391 T1 AT E297391T1 AT 01940240 T AT01940240 T AT 01940240T AT 01940240 T AT01940240 T AT 01940240T AT E297391 T1 ATE297391 T1 AT E297391T1
Authority
AT
Austria
Prior art keywords
treatment
cns disorders
indole derivatives
indole
derivatives
Prior art date
Application number
AT01940240T
Other languages
English (en)
Inventor
Benny Bang-Andersen
Jakob Felding
Jan Kehler
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE297391T1 publication Critical patent/ATE297391T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01940240T 2000-06-14 2001-06-13 Indolderivate zum gebrauch in der behandlung von zns-störungen ATE297391T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000919 2000-06-14
US21244500P 2000-06-16 2000-06-16
PCT/DK2001/000406 WO2001096328A1 (en) 2000-06-14 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
ATE297391T1 true ATE297391T1 (de) 2005-06-15

Family

ID=26068835

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04012325T ATE374197T1 (de) 2000-06-14 2001-06-13 Indolderivate zur behandlung von erkrankungen des zentralnervensystems
AT01940240T ATE297391T1 (de) 2000-06-14 2001-06-13 Indolderivate zum gebrauch in der behandlung von zns-störungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04012325T ATE374197T1 (de) 2000-06-14 2001-06-13 Indolderivate zur behandlung von erkrankungen des zentralnervensystems

Country Status (20)

Country Link
US (2) US6890916B2 (de)
EP (1) EP1294710B1 (de)
JP (1) JP2004503550A (de)
KR (1) KR20030007967A (de)
AR (1) AR028685A1 (de)
AT (2) ATE374197T1 (de)
AU (2) AU7388101A (de)
BG (1) BG107449A (de)
CA (1) CA2411412C (de)
CZ (1) CZ200335A3 (de)
DE (2) DE60111379T2 (de)
DK (1) DK1468996T3 (de)
ES (2) ES2243508T3 (de)
HR (1) HRP20021008A2 (de)
HU (1) HUP0301735A2 (de)
NO (1) NO323236B1 (de)
NZ (1) NZ523076A (de)
PT (2) PT1294710E (de)
SG (1) SG148840A1 (de)
WO (1) WO2001096328A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
EP1468996B1 (de) * 2000-06-14 2007-09-26 H. Lundbeck A/S Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2003236207A1 (en) * 2002-05-31 2003-12-19 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
AU2003257407A1 (en) * 2002-08-29 2004-03-19 H. Lundbeck A/S S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
GB0708186D0 (en) * 2007-04-27 2007-06-06 Merck Sharp & Dohme Therapeutic compounds
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
GB9718833D0 (en) * 1997-09-04 1997-11-12 Merck Sharp & Dohme Therapeutic agents
GB9810886D0 (en) * 1998-05-13 1998-07-22 Lilly Industries Ltd Pharmaceutical compounds
GB9825413D0 (en) * 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
CA2373855A1 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
WO2000078716A1 (fr) * 1999-06-24 2000-12-28 Toray Industries, Inc. ANTAGONISTES DU RECEPTEUR ADRENERGIQUE-α¿1B?
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines

Also Published As

Publication number Publication date
DK1468996T3 (da) 2008-01-07
KR20030007967A (ko) 2003-01-23
PT1468996E (pt) 2007-11-28
AU2001273881B8 (en) 2006-02-09
EP1294710B1 (de) 2005-06-08
NO20026005D0 (no) 2002-12-13
HUP0301735A2 (hu) 2003-08-28
NO20026005L (no) 2002-12-13
JP2004503550A (ja) 2004-02-05
ATE374197T1 (de) 2007-10-15
CA2411412A1 (en) 2001-12-20
HRP20021008A2 (en) 2005-02-28
US20050176729A1 (en) 2005-08-11
US7276508B2 (en) 2007-10-02
BG107449A (bg) 2003-09-30
AR028685A1 (es) 2003-05-21
US6890916B2 (en) 2005-05-10
PT1294710E (pt) 2005-10-31
ES2290587T3 (es) 2008-02-16
SG148840A1 (en) 2009-01-29
DE60111379T2 (de) 2006-03-16
DE60130691T2 (de) 2008-07-17
EP1294710A1 (de) 2003-03-26
AU7388101A (en) 2001-12-24
DE60130691D1 (de) 2007-11-08
DE60111379D1 (de) 2005-07-14
NO323236B1 (no) 2007-02-05
CZ200335A3 (cs) 2003-04-16
CA2411412C (en) 2008-09-02
WO2001096328A1 (en) 2001-12-20
US20030191133A1 (en) 2003-10-09
AU2001273881B2 (en) 2005-12-22
ES2243508T3 (es) 2005-12-01
NZ523076A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
NO20020384D0 (no) Amin og aminderivater som ligander for neuropeptid Y Y5 reseptor anvendelig ved behandling av fedme og andre forstyrrelser
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20014047D0 (no) Monoamin reopptaksinhibitorer for behandling av CNS forstyrrelser
DE60022867D1 (de) 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen
ATE297391T1 (de) Indolderivate zum gebrauch in der behandlung von zns-störungen
DE60103761D1 (de) Indolderivate zum gebrauch in der behandlung von zns-störungen
DE60118205D1 (de) 4-, 5-, 6- und 7-indolderivate die in der behandlung von störungen des cns benutzt werden können
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
ATE262525T1 (de) Indolderivate zur verwendung in der behandlung von zns-störungen
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
HK1059086A1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1294710

Country of ref document: EP

REN Ceased due to non-payment of the annual fee